Potential Role of the Gut Microbiome in Als a Systematic Review
Review
doi: ten.3390/microorganisms9050977.
Systematic Review: The Gut Microbiome and Its Potential Clinical Awarding in Inflammatory Bowel Disease
Affiliations
- PMID: 33946482
- PMCID: PMC8147118
- DOI: 10.3390/microorganisms9050977
Complimentary PMC article
Review
Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease
Microorganisms. .
Free PMC article
Abstract
Inflammatory bowel affliction (IBD) is a chronic relapsing-remitting systemic disease of the gastrointestinal tract. It is well established that the gut microbiome has a profound impact on IBD pathogenesis. Our aim was to systematically review the literature on the IBD gut microbiome and its usefulness to provide microbiome-based biomarkers. A systematic search of the online bibliographic database PubMed from inception to August 2020 with screening in accord with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted. I-hundred and forty-four papers were eligible for inclusion. There was a wide heterogeneity in microbiome analysis methods or experimental pattern. The IBD intestinal microbiome was mostly characterized by reduced species richness and diverseness, and lower temporal stability, while changes in the gut microbiome seemed to play a pivotal role in determining the onset of IBD. Multiple studies accept identified certain microbial taxa that are enriched or depleted in IBD, including leaner, fungi, viruses, and archaea. The two primary features in this sense are the decrease in beneficial leaner and the increase in pathogenic bacteria. Significant differences were also present between remission and relapse IBD status. Shifts in gut microbial community composition and abundance take proven to be valuable equally diagnostic biomarkers. The gut microbiome plays a major function in IBD, still studies demand to go from casualty to causality. Longitudinal designs including newly diagnosed handling-naïve patients are needed to provide insights into the function of microbes in the onset of intestinal inflammation. A better understanding of the human gut microbiome could provide innovative targets for diagnosis, prognosis, treatment and fifty-fifty cure of this relevant disease.
Keywords: Crohn's disease; biomarkers; gut microbiome; inflammatory bowel disease; ulcerative colitis.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential disharmonize of interest.
Figures

Gut microbiota disturbance in inflammatory bowel disease compared to good for you individuals. Upwardly arrow indicates increase and downward pointer decrease.
Like articles
-
A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration.
Public Health Rev. 2021 May v;42:1603990. doi: 10.3389/phrs.2021.1603990. eCollection 2021. Public Health Rev. 2021. PMID: 34692176 Free PMC commodity. Review.
-
Correlation Between the Gut Microbiome and Immunotherapy Response in Inflammatory Bowel Illness: A Systematic Review of the Literature.
Cureus. 2021 Aug 1;xiii(eight):e16808. doi: 10.7759/cureus.16808. eCollection 2021 Aug. Cureus. 2021. PMID: 34350086 Free PMC article. Review.
-
Development of Inflammatory Bowel Illness Is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice.
mSystems. 2017 Sep 5;2(5):e00036-17. doi: 10.1128/mSystems.00036-17. eCollection 2017 Sep-Oct. mSystems. 2017. PMID: 28904997 Costless PMC commodity.
-
Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome.
Microb Ecol. 2021 Nov;82(4):833-844. doi: 10.1007/s00248-021-01697-ix. Epub 2021 Mar 5. Microb Ecol. 2021. PMID: 33666710 Complimentary PMC article. Review.
-
Fecal transplantation for treatment of inflammatory bowel affliction.
Cochrane Database Syst Rev. 2018 Nov 13;11(eleven):CD012774. doi: x.1002/14651858.CD012774.pub2. Cochrane Database Syst Rev. 2018. PMID: 30480772 Free PMC commodity.
Cited by xiii manufactures
-
Inflammatory Bowel Illness and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin.
Front Microbiol. 2022 Mar 21;thirteen:856165. doi: 10.3389/fmicb.2022.856165. eCollection 2022. Front Microbiol. 2022. PMID: 35391730 Complimentary PMC commodity. Review.
-
Dietary Supplementation with Vitamin D, Fish Oil or Resveratrol Modulates the Gut Microbiome in Inflammatory Bowel Disease.
Int J Mol Sci. 2021 Dec 24;23(1):206. doi: 10.3390/ijms23010206. Int J Mol Sci. 2021. PMID: 35008631 Gratuitous PMC article. Review.
-
The Futurity of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Illness.
Gastroenterology. 2022 Apr;162(5):1525-1542. doi: 10.1053/j.gastro.2021.09.077. Epub 2022 January 4. Gastroenterology. 2022. PMID: 34995532 Review.
-
Going Beyond Bacteria: Uncovering the Role of Archaeome and Mycobiome in Inflammatory Bowel Disease.
Front Physiol. 2021 Dec 6;12:783295. doi: 10.3389/fphys.2021.783295. eCollection 2021. Front Physiol. 2021. PMID: 34938203 Free PMC article. Review.
-
Metabolomics Insights into Inflammatory Bowel Affliction: A Comprehensive Review.
Pharmaceuticals (Basel). 2021 November 20;14(11):1190. doi: 10.3390/ph14111190. Pharmaceuticals (Basel). 2021. PMID: 34832973 Free PMC article. Review.
References
-
- Hoyles L., Swann J. The Handbook of Metabolic Phenotyping. Elsevier Inc.; Amsterdam, The Netherlands: 2018. Influence of the human gut microbiome on the metabolic phenotype; pp. 535–560.
-
- Rajilic-Stojanovic M., Figueiredo C., Smet A., Hansen R., Kupcinskas J., Rokkas T., Andersen L., Machado J.C., Ianiro G., Gasbarrini A., et al. Systematic review: Gastric microbiota in wellness and affliction. Aliment. Pharmacol. Ther. 2020;51:582–602. doi: x.1111/apt.15650. - DOI - PubMed
-
- Thursby E., Juge N. Introduction to the human gut microbiota. Biochem. J. 2017;474:1823–1836. doi: 10.1042/BCJ20160510. - DOI - PMC - PubMed
-
- Pittayanon R., Lau J.T., Leontiadis G.I., Tse F., Yuan Y., Surette Thou., Moayyedi P. Differences in gut microbiota in patients with vs without inflammatory bowel diseases: A systematic review. Gastroenterology. 2020;158:930–946.e1. doi: 10.1053/j.gastro.2019.11.294. - DOI - PubMed
-
- Medina Benítez Due east., Fuentes Lugo D., Suárez Cortina L., Prieto Bozano Grand. Protocolos Diagnóstico-Terapéuticos de Gastroenterología, Hepatología y Nutrición Pediátrica SEGHNP-AEP. Ediciones Ergon; Madrid, Kingdom of spain: 2010. Enfermedad inflamatoria abdominal; pp. 151–160.
Publication types
LinkOut - more resources
-
Full Text Sources
- Europe PubMed Key
- Multidisciplinary Digital Publishing Institute (MDPI)
- PubMed Central
Source: https://pubmed.ncbi.nlm.nih.gov/33946482/
Post a Comment for "Potential Role of the Gut Microbiome in Als a Systematic Review"